IDXX Earnings

IDXX reported its earnings on 2026-02-02, showcasing a revenue of 1.09B against an estimate of 1.07B, resulting in a 1.92% surprise. The EPS was 3.08, surpassing the expected 2.93 by 5.12% . The stock experienced a -4.6% price change on the earnings day and a -4.01% change over the next five days, reflecting market reactions to the results.

Following IDXX's earnings announcement on 2026-02-02, the stock price moved by -4.60% on the day of the release. Over the subsequent five days, it saw a -4.01% change. Historically, IDXX's stock price tends to shift by an average of -3.22% in the 10 days leading up to earnings and +3.05% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate IDXX’s annual revenue to reach 1.10B, while the EPS is projected at 3.44. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 0.12% and EPS estimates Revise Downward by -0.06% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between IDXX's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Upward by 0.12%, while EPS estimates moved Revise Downward by -0.06% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, IDXX's stock price typically moves by -3.22% in the 10 days before its earnings and +3.05% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 3.44 and revenue of 1.10B.

The earnings call reflects strong financial performance with increased revenue and EPS guidance. Positive factors include significant growth in CAG Diagnostics, international expansion, and innovation in products like inVue and Cancer Dx. Despite some headwinds in wellness visits and pricing moderation, the overall outlook remains robust with improved margins and strategic expansion plans. The Q&A session confirms these positive trends, with management addressing concerns effectively, leading to a positive sentiment.